Edward Perez-Reyes Selected Research

Edward Perez-Reyes Research Topics

Disease

6	Epilepsy (Aura) 09/2023 - 07/2010
5	Seizures (Absence Seizure) 09/2023 - 07/2010
4	Temporal Lobe Epilepsy 07/2023 - 01/2012
4	Pain (Aches) 10/2018 - 07/2009
3	Absence Epilepsy (Childhood Absence Epilepsy) 07/2015 - 05/2005
2	Generalized Epilepsy 07/2010 - 02/2010
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2021
1	Nervous System Diseases (Neurological Disorders) 02/2021
1	Neuralgia (Stump Neuralgia) 06/2016
1	Peripheral Nerve Injuries 06/2016
1	Idiopathic Generalized Epilepsy 04/2014
1	Status Epilepticus (Complex Partial Status Epilepticus) 02/2014
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2010
1	Autism Spectrum Disorder 02/2010
1	Channelopathies 07/2008
1	Neoplasms (Cancer) 12/2004
1	Thyroid Neoplasms (Thyroid Cancer) 03/2002

Drug/Important Bio-Agent (IBA)

6	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2019 - 05/2005
5	Calcium Channels (Calcium Channel)IBA 10/2018 - 03/2002
2	Pilocarpine (Ocusert)FDA LinkGeneric 09/2023 - 02/2014
2	Transcription Factors (Transcription Factor)IBA 09/2023 - 04/2014
2	LithiumIBA 09/2023 - 02/2014
2	Proteins (Proteins, Gene)FDA Link 02/2021 - 10/2018
2	Analgesics (Analgesic Drugs)IBA 11/2013 - 07/2009
2	Protein Isoforms (Isoforms)IBA 02/2010 - 12/2004
1	Doxycycline (Periostat)FDA LinkGeneric 07/2023
1	AlbuminsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022
1	AMP-Activated Protein KinasesIBA 01/2022
1	Single-Chain AntibodiesIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Dynamins (Dynamin)IBA 02/2021
1	Streptozocin (Streptozotocin)FDA Link 02/2021
1	Mifepristone (RU 486)FDA Link 01/2018
1	Progesterone FDA LinkGeneric 01/2018
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	NeurosteroidsIBA 01/2018
1	AntibodiesIBA 06/2016
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 07/2015
1	N-Methylaspartate (NMDA)IBA 07/2015
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2015
1	CalciumIBA 07/2015
1	Ethosuximide (Zarontin)FDA LinkGeneric 02/2014
1	3,5- dichloro- N- (1- (2,2- dimethyltetrahydropyran- 4- ylmethyl)- 4- fluoropiperidin- 4- ylmethyl)benzamideIBA 02/2014
1	PotassiumIBA 02/2014
1	EugenolIBA 11/2013
1	Adenosine (Adenocard)FDA LinkGeneric 01/2012
1	Ligand-Gated Ion ChannelsIBA 07/2010
1	voltage-dependent calcium channel (P-Q type)IBA 07/2010
1	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 07/2010
1	Parasympatholytics (Antispasmodics)IBA 05/2010
1	AldosteroneIBA 02/2010
1	Thioctic Acid (Lipoic Acid)IBA 07/2009
1	AcidsIBA 07/2009

Therapy/Procedure

3	Therapeutics 09/2023 - 10/2020
1	Low-Level Light Therapy (LLLT) 02/2021
1	Electrodes (Electrode) 01/2021